Does intellectual capital investment enhance firm performance? Evidence from pharmaceutical sector in China.
Resource URI: https://dblp.l3s.de/d2r/resource/publications/journals/taasm/GeX21
Home
|
Example Publications
Property
Value
dcterms:
bibliographicCitation
<
http://dblp.uni-trier.de/rec/bibtex/journals/taasm/GeX21
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Fengli_Ge
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Jian_Xu
>
foaf:
homepage
<
http://dx.doi.org/doi.org%2F10.1080%2F09537325.2020.1862414
>
foaf:
homepage
<
https://doi.org/10.1080/09537325.2020.1862414
>
dc:
identifier
DBLP journals/taasm/GeX21
(xsd:string)
dc:
identifier
DOI doi.org%2F10.1080%2F09537325.2020.1862414
(xsd:string)
dcterms:
issued
2021
(xsd:gYear)
swrc:
journal
<
https://dblp.l3s.de/d2r/resource/journals/taasm
>
rdfs:
label
Does intellectual capital investment enhance firm performance? Evidence from pharmaceutical sector in China.
(xsd:string)
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Fengli_Ge
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Jian_Xu
>
swrc:
number
9
(xsd:string)
swrc:
pages
1006-1021
(xsd:string)
owl:
sameAs
<
http://bibsonomy.org/uri/bibtexkey/journals/taasm/GeX21/dblp
>
owl:
sameAs
<
http://dblp.rkbexplorer.com/id/journals/taasm/GeX21
>
rdfs:
seeAlso
<
http://dblp.uni-trier.de/db/journals/taasm/taasm33.html#GeX21
>
rdfs:
seeAlso
<
https://doi.org/10.1080/09537325.2020.1862414
>
dc:
title
Does intellectual capital investment enhance firm performance? Evidence from pharmaceutical sector in China.
(xsd:string)
dc:
type
<
http://purl.org/dc/dcmitype/Text
>
rdf:
type
swrc:Article
rdf:
type
foaf:Document
swrc:
volume
33
(xsd:string)